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ICH USUWANIA ‒ WYBRANE ZAGADNIENIA
A b s t r a c t
The article discusses the occurrence of selected cytostatic drugs in the aquatic environment. The authors 
start with a preliminary introduction to the characteristics of the most commonly used cytostatic drugs. 
Then, based on the review of the literature they show that such drugs occur in small amounts in an aqueous 
medium and that there is no reliable research data on the long-term exposure of aquatic organisms to 
cytostatics. Until now, the studies on the stability of some cytostatics showed that these compounds were 
extremely stable, not only in natural waters, but also at wastewater treatment plants (WWTPs). In spite 
of the advanced treatment technologies used at wastewater treatment plants, cytostatics pass relatively 
easily through the treatment line and end up in surface waters, thus posing a threat to water quality.
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S t r e s z c z e n i e
W artykule przedstawiono zagadnienia związane z występowaniem wybranych leków cytostatycznych 
w środowisku wodnym. Dokonano wstępnej charakterystyki najczęściej stosowanych leków cytostatycz-
nych. W oparciu o przegląd literatury wykazano, że związki te występują w środowisku wodnym w nie-
wielkich ilościach i nie ma wiarygodnych badań dotyczących długotrwałego narażenia organizmów wod-
nych na działanie cytostatyków. Wyniki dotychczasowych badań nad stabilnością wybranych cytostatyków 
wykazały, że związki te są wyjątkowo stabilne nie tylko w wodach naturalnych, ale także w warunkach 
panujących w oczyszczalniach ścieków. Mimo stosowania najnowszych technologii w oczyszczaniu ście-
ków, rozpatrywane cytostatyki, w mniejszym lub większym stopniu, przedostają się przez oczyszczalnie 
ścieków i trafiają do wód powierzchniowych, stanowiąc zagrożenie dla ich jakości,




The presence of contaminants of pharmaceutical origin in the aquatic environment is not 
a new issue. In the 1970s, clofibric acid was detected in surface waters in today’s Germany. 
This compound is a metabolite of lipid regulators, including clofibrate and etofibriate. In the 
1980s, the presence of thirty-two other different drugs and their metabolites was detected. 
Up to the year 2007, more than ninety pharmaceuticals have been identified all over the 
world in the seas, lakes, rivers, groundwater, soil and lake sediments [4]. New developments 
in medical and pharmaceutical sciences brought along tens of thousands of pharmaceuticals 
used for the diagnosis, prevention and treatment of numerous diseases and disorders. In many 
cases, once the drug has been introduced to the human body, it undergoes biotransformation 
into predominantly hydrophilic forms in the liver; only in the form of metabolites are the 
drugs excreted by kidneys, which is the major manner of their removal from the body. 
However, the compounds which are not absorbed from the gastrointestinal tractor readily 
soluble electrolytes can pass through the body in an unchanged form [25].
Given the continuous growth of the world’s population, one can expect a gradual increase 
in the demand and consumption of pharmaceuticals; it may be associated with the increased 
presence of these compounds in the aquatic environment. There have been well-known cases 
with a negative impact of pharmaceuticals on animals, including the impact of diclofenac 
(from the group of non-steroidal anti-inflammatory drugs) on kidney failure and the death 
of vultures in Asia [6] or the impact of the synthetic hormone ethinylestradiol (EE2) on 
changes of the sex of fish [8, 9, 15]. Looking at the growing number of people suffering 
from cancer, Cytostatic drugs maybe a potential threat to the aquatic environment. This 
paper attempts to describe the occurrence of some anti-cancer drugs in the environment 
and estimate the efficiency of their removal in wastewater treatment processes.
2. Characteristic of cytostatics
Cytostatics comprise a group of natural and synthetic compounds used widely in cancer 
treatment (chemotherapy) and are toxic to rapidly dividing tumor cells. Since they may 
also be harmful for other rapidly dividing cells (such as bone marrow, hair and mucous 
membranes), the drugs are highly dangerous with many undesirable side effects, such as 
anemia, nausea, vomiting and alopecia. Furthermore, cytostatics exhibit carcinogenic, 
mutagenic and teratogenic effects, and they are therefore considered potentially the most 
dangerous pollutants in the water environment [11, 12]. Currently, some of the most popular 
anti-cancer drugs are cyclophosphamide (CP) and ifosfamide (IF), which are alkylating 
cytostatic agents, and 5-fluorouracil (5-FU), which belongs to a group of antimetabolites.
Cytostatic drugs act differently, depending on the type of drug; but their main role 
is to inhibit or completely block the replication of DNA in the tumor cell. The above- 
-mentioned cytostatics (cyclophosphamide, ifosfamide, and 5-fluorouracil) are not only 
used in chemotherapy of different types of cancers, such as cancer of breasts, bronchial, 
testes, ovaries (CP, IF) and cancer of the digestive system (5-FU) but also in the treatment 
of leukemia, lymphoma and autoimmune diseases. They are also used for immunosuppression 
after organ transplantation (CP, IF) [9].
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3. Cytostatics in water environment
Pharmacologically active substances present in the environment originate from numerous 
different sources, as shown in Fig. 1 [16]. Pharmaceuticals, including cytostatics, are not 
always fully metabolized in the body. The average percentage of original compounds 
excreted in urine in the case of CP, IF, and 5-FU is 21%, 26% and 18%, respectively [2]. 
The use of cytostatics in chemotherapy means that the main source of pollution with these 
compounds is wastewater from hospitals or hospital patients undergoing chemotherapy.
The previous research on biodegradation of alkylating cytostatics (in the 1990s) [1, 5‒7] 
at higher concentrations, as well as the research conducted at lower concentrations in 
Switzerland in 2006 [3], have demonstrated the exceptional resistance of cyclophosphamide 
and ifosfamide to biodegradation in activated sludge. This means that the cytostatic drugs 
pass to the aquatic environment despite the use of advanced treatment technologies. A study 
conducted in Switzerland indicated the presence of CP in the effluent from the Mannedorf 
WWTP (CP = 2 ng/l without chemotherapy at a local hospital, and 10 ng/l when such 
treatment took place) and CP and IF in the effluent from the  Zurich WWTP (CP = 2.1‒4 ng/l 
and IF = 1.7‒6 ng/l) [3]. The same study showed the presence of these compounds in the 
river Limmat, downstream from the Zurich WWTP effluent discharge (CP = 0.15‒0.17 ng/l 
and IF = 0.08‒0.14 ng/l). Other studies have shown that cyclophosphamide concentrations 
Fig. 1. Potential sources and pathways of pharmaceutical pollution in water and soil
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in surface water samples reached the level of 64.8 ng/l [21]. However, along with a growing 
number of cancer cases and a higher consumption of cytostatic drugs, concentrations 
of these substances in the aquatic environment may also increase. Such a trend has been 
confirmed by, for example, studies carried out in Spain, where ifosfamide was detected 
in local surface waters [26]. Cytostatics (CP, IF, 5-FU) were also detected in surface waters 
throughout Taiwan; water samples were taken from rivers located in the regions of Taipei and 
Kaohsiung-Pingtung. In the rivers of the Taipei region, the concentrations of 5-fluorouracil, 
cyclophosphamide and ifosfamide were 5‒70 ng/l, 1.9‒13 ng/l and 1.9‒8.9 ng/l, respectively. 
However, in the rivers of the Kaohsiung-Pingtung region, the concentrations of these 
compounds were 35‒160 ng/l, 0.9‒96 ng/l and 0.1‒4.7 ng/l, respectively [17]. Although there 
are small quantities of these compounds present in the aquatic environment, there is lack 
of reliable research data on the long-term exposure of aquatic organisms to the cytostatics. 
In such situations, the best solution seems to be reduced emissions of these compounds into 
the aquatic environment.
4. Methods
Though cytostatic concentrations in hospital wastewater are sometimes reported at the 
level of µg/l [17], their actual concentrations at the wastewater treatment plant are much 
lower due to dilution. Techniques used for the determination of cytostatics include gas 
chromatography coupled with a mass spectrometer (GC-MS – gas chromatography mass 
spectrometry) [3] and liquid chromatography coupled with a mass spectrometer (LC-MS 
– liquid chromatography mass spectrometry). However, sometimes the detection of very 
low concentrations (ng/l or lower [3, 17]) requires the use of more sophisticated analytical 
techniques with low limits of quantification like high performance liquid chromatography 
HPLC-MS. Another common technique is liquid chromatography coupled with tandem 
mass spectrometry (LC-MS/MS – liquid chromatography-tandem mass spectrometry) [3, 19, 
20, 22] and HPLC-MS/MS [18].
5. Treatment efficiency
If chemotherapy were performed only in hospitals, pretreatment of hospital wastewater 
would sufficiently reduce the amount of anti-cancer drugs discharged to the wastewater 
treatment plant. However, oral chemotherapy is one of the methods of treatment. Undoubted 
advantages of this therapy include the comfort of the patient (treatment at home) and no 
need for continuous hospitalization – this assures a better sense of stability and well-being. 
On the other hand, a significant disadvantage of this solution is the excretion of metabolites 
and parent substances of cytostatics with domestic sewage; in such cases, wastewater cannot 
be pre-treated before its discharge to the treatment plant, this is why it is vital to provide 
efficient treatment and disposal of cytostatics at the municipal wastewater treatment plant.
The study on the stability of cyclophosphamide and ifosfamide showed that 
these compounds are extremely stable, not only in natural waters, but also under the 
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conditions prevailing at the wastewater treatment plants [3, 10, 13, 14, 23, 24]. In the 
case of 5-fluorouracil [17], the authors report the following results of its biodegradation: 
in activated sludge ‒ 38% after 3 days and 65% after 4 days; aerobic biodegradation – less 
than 60% after 50 days. Despite the use of the latest wastewater treatment technologies, 
cytostatics pass through the plants (to a lesser or greater extent) and end up in surface waters. 
Table 1 shows cyclophosphamide and ifosfamide concentrations observed in the influents 
and effluents of sewage treatment plants in the canton of Zurich, Switzerland [3].
T a b l e  1




Influent Effluent Influent Effluent
Mannedorf
20‒23.09.2002 ~4 ~2 < 15 < 2
24‒27.09.2002 11 10 < 15 < 2
Zurich
23.03‒03.04.2005 5 4 5 6
18‒24.2005 2 2.1 ~1.4 1.7
Tests carried out on samples from sewage treatment plants in the region of Taipei 
in Taiwan [17] confirmed the poor removal of cytostatics in the local sewage treatment 
plant; concentrations in the plant influent and effluent were as follows: cyclophosphamide 
280 ng/l and 80 ng/l; ifosfamide 12 ng/l and 15 ng/l; 5-fluorouracil 8.3 ng/l and 10 ng/l.
T a b l e  2
Degradation of CP and 5-FU [18]
Compound Initial concentration Method
Residual concentration
[C/C0]






(5 mg/l) ~0.30 ~0.10
UV + Degussa P25
(5 mg/l) ~0.01 ~0.00
Cyclophosphamide 27.6 mg/l
UV + Degussa P25
(20 mg/l) ~0.39 ~0.05
UV + Degussa P25
(300 mg/l) ~0.18 ~0.00
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Since certain cytostatics are resistant to biodegradation, alternative methods of their 
removal from wastewater and natural waters should be investigated. The latest studies on 
the photocatalytic oxidation of cyclophosphamide and 5-FU with e.g. UV/TiO2 [18] show 
the possibility of successful oxidation of these compounds. In this work, the authors used 
HPLC-MS/MS technique to determine CP and 5-FU concentrations; the results have been 
summarized in Tab. 2.
6. Conclusions
– Pharmaceuticals are becoming a serious problem for the well-being of organisms living 
in water that receives the effluent from wastewater treatment plants.
– In many countries, cytostatics have been found in the effluent from wastewater treatment 
plants and surface waters.
– Poor removal of some cytostatics during the treatment process and their high resistance 
to biodegradation suggest the need for other methods to eliminate these compounds from 
wastewater.
– There are no research studies that would clearly indicate the effects of the prolonged 
exposure of organisms to anti-cancer drugs. Therefore, it is difficult to introduce measures 
restricting their emissions into surface waters.
– The introduction of regulations defining the allowed and safe maximum concentrations 
of  substances in the aquatic environment seems to be an urgent task for both the European 
Union and Poland.
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